Related Experiment Video
Updated: Jan 26, 2026

The Lambda Select cII Mutation Detection System
Published on: April 26, 2018
Screening for mutations in selected miRNA genes in hypogonadotropic hypogonadism patients
Anna-Pauliina Iivonen1, Johanna Känsäkoski1, Kirsi Vaaralahti1
1Institute of Biomedicine/Physiology, Biomedicum Helsinki and Stem Cells and Metabolism Research Program, University of Helsinki, Helsinki, Finland.
Abstract:
In approximately half of congenital hypogonadotropic hypogonadism (cHH) patients, the genetic cause remains unidentified. Since the lack of certain miRNAs in animal models has led to cHH, we sequenced human miRNAs predicted to regulate cHH-related genes (MIR7-3, MIR141, MIR429 and MIR200A-C) in 24 cHH patients with Sanger sequencing. A heterozygous variant in MIR200A (rs202051309; general population frequency of 0.02) was found in one patient. Our results suggest that mutations in the studied miRNAs are unlikely causes of cHH. However, the complex interplay between miRNAs and their target genes in these diseases requires further investigations.
Insights
Genetic sequencing in congenital hypogonadotropic hypogonadism (cHH) patients found no strong links to mutations in specific microRNAs (miRNAs). Further research is needed to understand the complex role of miRNAs in cHH.
Area of Science:
- Genetics
- Endocrinology
- Molecular Biology
Background:
- Congenital hypogonadotropic hypogonadism (cHH) is a rare genetic disorder affecting reproductive development.
- The genetic basis for cHH remains unknown in about half of affected individuals.
- MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression and have been implicated in various developmental processes.
Purpose of the Study:
- To investigate the potential role of specific microRNAs (miRNAs) in the genetic etiology of congenital hypogonadotropic hypogonadism (cHH).
- To sequence candidate miRNAs predicted to target genes associated with cHH in a cohort of patients.
- To identify any potentially causative variants in these miRNAs that could explain cHH in undiagnosed cases.
Main Methods:
- Sanger sequencing was employed to analyze the coding regions of selected miRNAs (MIR7-3, MIR141, MIR429, and MIR200A-C).
- The study included a cohort of 24 patients diagnosed with congenital hypogonadotropic hypogonadism (cHH).
- The frequency of identified variants was compared against general population data.
Main Results:
- A single heterozygous variant in MIR200A (rs202051309) was detected in one cHH patient.
- The identified variant had a known general population frequency of 0.02, suggesting it is not a rare or novel mutation.
- No other significant variants were found in the sequenced miRNAs across the patient cohort.
Conclusions:
- Mutations in the investigated miRNAs (MIR7-3, MIR141, MIR429, MIR200A-C) are unlikely to be a primary cause of congenital hypogonadotropic hypogonadism (cHH).
- The findings suggest that while these specific miRNAs may not be directly implicated, the broader role of miRNA-gene interactions in cHH warrants further investigation.
- Future research should explore the complex regulatory networks involving miRNAs and their target genes in the context of cHH pathogenesis.
Related Concept Videos
Mutation, Gene Flow, and Genetic Drift
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Viral Mutations
What is Natural Selection?
Gene Flow

